1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	80	80		-	-	9-11	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	con	con	SPS00	C0332287	atributo	17-20	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	antecedentes	antecedente	NCMP000	C0332119_1	situación_1	21-33	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	de	de	SPS00	C0332119_2	situación_2	34-36	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	hipertensión	hipertensión	NCFS000	C0020538_1	trastorno_1	37-49	569_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
9	arterial	arterial	NC00SC0	C0020538_2	trastorno_2	50-58	569_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-	8	3356	LOC
10	,	,	Fc	-	-	58-59	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	hipercolesterolemia	hipercolesterolemia	NCFS000	C0020443	trastorno	60-79	569_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
12	,	,	Fc	-	-	79-80	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	diabetes	diabetes	NCFN000	C0011849_1	trastorno_1	81-89	569_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
14	mellitus	mellitus	AQ0CN0	C0011849_2	trastorno_2	90-98	569_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-	13	72	MultiE
15	,	,	Fc	-	-	98-99	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	obesidad	obesidad	NCFS000	C0028754#C0451819#C1563743	trastorno	100-108	569_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
17	grado	grado	NCMS000	C0687695#C0205615_1	calificador_1	109-114	569_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	16	3356	Modif
18	I	i	NCFS000	C0687695#C0205615_2	calificador_2	115-116	569_QUEST_clinical_caseMIR	SENT1	I-Calificador	-	17	7	MultiE
19	e	y	CC	C1706368	calificador	117-118	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	insuficiencia	insuficiencia	NCFS000	C0403447_1	trastorno_1	119-132	569_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
21	renal	renal	AQ0CS0	C0403447_2	trastorno_2	133-138	569_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-	20	3356	LOC
22	crónica	crónico	AQ0FS0	C0403447_3	trastorno_3	139-146	569_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	20	3356	Modif
23	.	.	Fp	-	-	146-147	569_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Se	se	P00CN000	-	-	148-150	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	encuentra	encontrar	VMIP3S0	-	-	151-160	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	en	en	SPS00	C1720294#C0332285	calificador#atributo	161-163	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	164-175	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	con	con	SPS00	C0332287	atributo	176-179	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	enalapril	enalapril	NC00SC0	C0014025	sustancia	180-189	569_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-	-	-	-
7	10	10	Z	-	-	190-192	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	mg	mg	NCMN000	-	-	193-195	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	cada	cada	NC00SC0	C1457900	calificador	196-200	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	12	12	Z	-	-	201-203	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	h	h	NCMN000	C0439227	calificador	204-205	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	,	,	Fc	-	-	205-206	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	furosemida	furosemida	NC00SC0	C0016860	producto#sustancia	207-217	569_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-	-	-	-
14	40	40	Z	-	-	218-220	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	mg	mg	NCMN000	-	-	221-223	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	una	una		C0205447_1	calificador_1	224-227	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
17	al	al	SP+DA	-	-	228-230	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
18	día	día	NCMS000	C0439228#C0332169	calificador	231-234	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
19	,	,	Fc	-	-	234-235	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
20	metformina	metformina	NC00SC0	C0025598	producto#sustancia	236-246	569_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-	-	-	-
21	850	850	Z	-	-	247-250	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
22	mg	mg	NCMN000	-	-	251-253	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
23	cada	cada	NC00SC0	C1457900	calificador	254-258	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
24	12	12	Z	-	-	259-261	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
25	h	h	NCMN000	C0439227	calificador	262-263	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
26	,	,	Fc	-	-	263-264	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
27	simvastatina	simvastatina	NC00SC0	C0074554	producto#sustancia	265-277	569_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-	-	-	-
28	20	20	Z	-	-	278-280	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
29	mg	mg	NCMN000	-	-	281-283	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
30	cada	cada	DI0CS0	C1457900	calificador	284-288	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
31	24h	24h		-	-	289-292	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
32	y	y	CC	C1706368	calificador	293-294	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
33	lorazepam	lorazepam	NC00SC0	C0024002	sustancia	295-304	569_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-	-	-	-
34	1	1	Z	-	-	305-306	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
35	mg	mg	NCMN000	-	-	307-309	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
36	por	por	SPS00	C0678226	atributo	310-313	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
37	las	el	DA0FP0	-	-	314-317	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
38	noches	noche	NCFP000	C0240526	calificador	318-324	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
39	.	.	Fp	-	-	324-325	569_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	Acude	acudir	VMIP3S0	-	-	326-331	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	a	a	SPS00	-	-	332-333	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	urgencias	urgencia	NCFP000	C0439609	calificador	334-343	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	por	por	SPS00	C0678226	atributo	344-347	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	empeoramiento	empeoramiento	NCMS000	-	-	348-361	569_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
6	de	de	SPS00	C0332285	atributo	362-364	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	su	su	DP3CS0	-	-	365-367	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	disnea	disnea	NCFS000	C0013404#C0553668	hallazgo	368-374	569_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	5	3358	Causada_por
9	hasta	hasta	SPS00	-	-	375-380	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	hacer	hacer	VMN0000	-	-	381-386	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	se	se	PP3CN000	-	-	386-388	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	de	de	SPS00	C0332285	atributo	389-391	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	mínimos	mínimo	AQ0MP0	C0547040#C1282907	calificador	392-399	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	esfuerzos	esfuerzo	NCMP000	-	-	400-409	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	.	.	Fp	-	-	409-410	569_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	A	a	SPS00	-	-	411-412	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	la	el	DA0FS0	-	-	413-415	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	416-427	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	428-434	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	destaca	destacar	VMIP3S0	-	-	435-442	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	PA	pa	NC00YL0	-	-	443-445	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	176/98	176/98	Z	-	-	446-452	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
8	mmHg	mmHg	NCMP000	-	-	453-457	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	,	,	Fc	-	-	457-458	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
10	FC	fc	NC00YL0	-	-	459-461	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	103	103		-	-	462-465	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	lpm	lpm	NC00YL0	-	-	466-469	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
13	.	.	Fp	-	-	469-470	569_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	Se	se	P00CN000	-	-	471-473	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	encuentra	encontrar	VMIP3S0	-	-	474-483	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	taquipneica	taquipnea	NCFS00V	C0231835	hallazgo	484-495	569_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-	-	-	-
4	con	con	SPS00	C1521798_1	atributo_1	496-499	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	tendencia	tendencia	NCFS000	C1521798_2	atributo_2	500-509	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	al	al	SP+DA	-	-	510-512	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	sueño	sueño	NCMS000	C0037313	entidad_observable	513-518	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	y	y	CC	C1706368	calificador	519-520	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
9	una	una		C0205447_1	calificador_1	521-524	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
10	saturación	saturación	NCFS000	-	-	525-535	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
11	de	de	SPS00	C0332285	atributo	536-538	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
12	oxígeno	oxígeno	NCMS000	C0030054	sustancia	539-546	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
13	del	del	SP+DA	-	-	547-550	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
14	88	88	Z	-	-	551-553	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
15	%	%	Ft	-	-	553-554	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
16	.	.	Fp	-	-	554-555	569_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

1	A	a	SPS00	-	-	556-557	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
2	la	el	DA0FS0	-	-	558-560	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
3	auscultación	auscultación	NCFS000	C0004339	procedimiento	561-573	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
4	está	estar	VAIP3S0	-	-	574-578	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
5	arrítmica	arrítmico	AQ0FS0	-	-	579-588	569_QUEST_clinical_caseMIR	SENT6	B-Grp_Enfermedad	-	-	-	-
6	a	a	SPS00	-	-	589-590	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
7	108	108		-	-	591-594	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
8	lpm	lpm	NC00YL0	-	-	595-598	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
9	con	con	SPS00	C0332287	atributo	599-602	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
10	crepitantes	crepitantes	NCCP000	-	-	603-614	569_QUEST_clinical_caseMIR	SENT6	B-Grp_Enfermedad	-	-	-	-
11	bilaterales	bilateral	AQ0CP0	C0238767	calificador	615-626	569_QUEST_clinical_caseMIR	SENT6	B-Calificador	-	10	3361	Modif
12	hasta	hasta	SPS00	-	-	627-632	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
13	campos	campo	NCMP000	-	-	633-639	569_QUEST_clinical_caseMIR	SENT6	B-Estructura_Corporal	-	10	3361	LOC
14	medios	medio	NCMP000	C2939193#C0205098#C0444598#C0549183	calificador	640-646	569_QUEST_clinical_caseMIR	SENT6	I-Estructura_Corporal	-	13	72	MultiE
15	.	.	Fp	-	-	646-647	569_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-

1	Presenta	presentar	VMIP3S0	-	-	648-656	569_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
2	edemas	edema	NCMP000	C0013604	anomalía_morfológica#hallazgo#entidad_observable	657-663	569_QUEST_clinical_caseMIR	SENT7	B-Grp_Enfermedad	-	-	-	-
3	en	en	SPS00	C1720294#C0332285	calificador#atributo	664-666	569_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-
4	miembros	miembro	NCMP000	C0015385	estructura_corporal	667-675	569_QUEST_clinical_caseMIR	SENT7	B-Estructura_Corporal	-	2	3362	LOC
5	inferiores	inferior	AQ0CP0	C0542339#C0205104	calificador	676-686	569_QUEST_clinical_caseMIR	SENT7	I-Estructura_Corporal	-	4	23	MultiE
6	.	.	Fp	-	-	686-687	569_QUEST_clinical_caseMIR	SENT7	-	-	-	-	-

1	¿	¿	Fia	-	-	688-689	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	689-693	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	694-696	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
4	las	el	DA0FP0	-	-	697-700	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	701-711	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
6	es	ser	VSIP3S0	-	-	712-714	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
7	INCORRECTA	incorrecto	AQ0FS0	-	-	715-725	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-
8	?	?	Fit	-	-	725-726	569_QUEST_clinical_caseMIR	SENT8	-	-	-	-	-

